文献速递胃肠外科围术期管理与 ERAS

术前阿片类药物使用与结直肠加速康复路径内术后并发症风险增加相关

Preoperative opioid use is associated with increased risk of postoperative complications within a colorectal-enhanced recovery protocol.
PubMed 文献 · Surg Endosc · 2020-05-11

本研究为回顾性队列研究,纳入2013年8月至2017年6月择期结直肠手术患者707例,其中术前阿片类药物暴露者232例(32.8%)。结果显示暴露组术后并发症发生率(28.5% vs 15.0%,p<0.01)和中位住院时间(4.0 vs 3.0天,p<0.01)均高于未暴露组,多因素回归显示术前阿片类药物使用与术后并发症独立相关(p=0.001)。

要点

  • 术前阿片类药物暴露者术后并发症发生率更高(28.5% vs 15.0%)。
  • 暴露组中位住院时间更长(4.0 vs 3.0天)。
  • 术前阿片类药物使用是术后并发症的独立危险因素(p=0.001)。

核心结论

  • 在加速康复路径内的择期结直肠手术患者中,术前阿片类药物使用与术后并发症风险增加相关。

研究设计与样本

  • 回顾性队列研究,纳入2013年8月至2017年6月择期结直肠手术患者707例,比较术前阿片类药物暴露组(232例,32.8%)与未暴露组。

主要发现

  • 暴露组术后并发症发生率高于未暴露组(28.5% vs 15.0%,p<0.01)。
  • 暴露组中位住院时间长于未暴露组(4.0 vs 3.0天,p<0.01)。
  • 暴露组患者更年轻(57.9 vs 61.9岁,p<0.01),吸烟比例更高(27.6% vs 17.1%,p<0.01),腹腔镜手术比例更低(44.8% vs 58.1%,p<0.01)。
  • 暴露组中位吗啡当量用量更高(65.0 vs 20.1 mg,p<0.01),但加速康复路径其他要素依从性相当。
  • 多因素回归显示术前阿片类药物使用与术后并发症独立相关(p=0.001)。

临床怎么用

  • 对择期结直肠手术患者应评估术前阿片类药物使用情况,识别术后并发症高风险人群。
  • 可考虑将术前阿片类药物减量或替代策略纳入加速康复路径,以进一步降低手术并发症风险。

局限性

  • 本研究为回顾性队列研究,可能存在残余混杂。
  • 暴露组与未暴露组在年龄、吸烟和腹腔镜比例等方面存在基线差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As the opioid epidemic escalates, preoperative opioid use has become increasingly common. Recent studies associated preoperative opioid use with postoperative morbidity. However, limited study of its impact on patients within enhanced recovery protocols (ERP) exists. We assessed the impact of preoperative opioid use on postoperative complications among colorectal surgery patients within an ERP, hypothesizing that opioid-exposed patients would be at increased risk of complications. METHODS: Elective colorectal cases from August 2013 to June 2017 were reviewed in a retrospective cohort study comparing preoperative opioid-exposed patients to opioid-naïve patients. Postoperative complications were defined as a composite of complications captured by the American College of Surgeons National Surgical Quality Improvement Program. Logistic regression identified risk factors for postoperative complications. RESULTS: 707 patients were identified, including 232 (32.8%) opioid-exposed patients. Opioid-exposed patients were younger (57.9 vs 61.9 years; p < 0.01) and more likely to smoke (27.6 vs 17.1%; p < 0.01). Laparoscopic procedures were less common among opioid-exposed patients (44.8 vs 58.1%; p < 0.01). Median morphine equivalents received were higher in opioid-exposed patients (65.0 vs 20.1 mg; p < 0.01), but compliance to ERP elements was otherwise equivalent. Postoperative complications were higher among opioid-exposed patients (28.5 vs 15.0%; p < 0.01), as was median length of stay (4.0 vs 3.0 days; p < 0.01). Logistic regression identified multiple patient- and procedure-related factors independently associated with postoperative complications, including preoperative opioid use (p = 0.001). CONCLUSION: Preoperative opioid use is associated with increased risk of postoperative complications in elective colorectal surgery patients within an ERP. These results highlight the negative impact of opioid use, suggesting an opportunity to further reduce the risk of surgical complications through ERP expansion to include preoperative mitigation strategies for opioid-exposed patients.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Hassinger TE, Krebs ED, Turrentine FE, et al. Preoperative opioid use is associated with increased risk of postoperative complications within a colorectal-enhanced recovery protocol. Surg Endosc. 2020. PMID: 32394171. doi:10.1007/s00464-020-07603-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。